JP Morgan Healthcare Conference, Day One: Waters, Sigma-Aldrich, Agilent | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated from a previous version to clarify information about Agilent's life science business and overall business in the Asia/Pacific region.

SAN FRANCISCO (GenomeWeb News) – The 30th Annual JP Morgan Healthcare Conference kicked off Monday here with several life science tools firms making presentations to some of the more than 8,000 investors and company representatives in attendance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.